Sumant Ramachandra
CIK 1439368 · SVP & Chief Scientifc Ofcr · last filed 2026-06-12
Sumant Ramachandra is a SVP & Chief Scientifc Ofcr who has filed 45 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing, for LYEL, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$6.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $135.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$135.5K
3
45
-$6.07M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | Director | 10,000 | $13.55 | $135.5K | $115.2K | 4 | 2026-06-12 |
| HOSPIRA INC (HSP) Delisted | SVP & Chief Scientifc Ofcr | 171,235 | — | — | -$6.18M | 40 | 2015-09-03 |
| MADRIGAL PHARMACEUTICALS, INC. (SNTA) Delisted | President, R&D | 75,000 | — | — | $0 | 1 | 2013-03-13 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-12 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2025-05-19 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2025-03-25 | LYEL | Buy (P) | +200,000 | $115.2K | EDGAR |
| 2024-11-01 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2015-09-03 | HOSPIRA INC (HSP) Delisted | Mixed | −89,424 | -$16.05M | EDGAR |
| 2015-06-29 | HOSPIRA INC (HSP) Delisted | Tax (F) | −2,161 | -$191.9K | EDGAR |
| 2015-03-05 | HOSPIRA INC (HSP) Delisted | Tax (F) | −2,348 | -$205.5K | EDGAR |
| 2015-02-27 | HOSPIRA INC (HSP) Delisted | Grant (A) | +34,480 | $3.02M | EDGAR |
| 2014-07-01 | HOSPIRA INC (HSP) Delisted | Tax (F) | −1,925 | -$97.9K | EDGAR |
| 2014-03-03 | HOSPIRA INC (HSP) Delisted | Grant (A) | +22,639 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.